Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women

Journal of Steroid Biochemistry and Molecular Biology

Volumn 128, Issue 3-5, 2012, Pages 139-144

  Issa, Mustafa H ^a   Cerda, Alvaro ^a   Genvigir, Fabiana D V ^a   Cavalli, Selma A ^a   Bertolami, Marcelo C ^b   Faludi, Andre A ^b   Hirata, Mario H ^a   Hirata, Rosario D C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Apolipoprotein E (apoE); Atorvastatin; Gene expression; Hormone therapy (HT); Menopause; Single nucleotide polymorphism (SNP)

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; ATORVASTATIN; CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NORETHISTERONE ACETATE; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HORMONAL THERAPY; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT OUTCOME;

AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; APOLIPOPROTEINS; APOLIPOPROTEINS E; BRAZIL; CHOLESTEROL, LDL; DOWN-REGULATION; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; ORPHAN NUCLEAR RECEPTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PYRROLES; RNA, MESSENGER;

EID: 84855653939     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.11.001     Document Type: Article

References (37)

1. V. Bittner Perspectives on dyslipidemia and coronary heart disease in women: an update Curr. Opin. Cardiol. 21 6 2006 602 607 (Pubitemid 44624547)
2. R.P. Middelberg, T.D. Spector, R. Swaminathan, and H. Snieder Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause Arterioscler. Thromb. Vasc. Biol. 22 7 2002 1142 1147 (Pubitemid 34764865)
3. R.W Mahley, and S.C. Rall Jr. Apolipoprotein E: far more than a lipid transport protein Annu. Rev. Genomics Hum. Genet. 1 2000 507 537
4. K. Greenow, N.J. Pearce, and D.P. Ramji The key role of apolipoprotein E in atherosclerosis J. Mol. Med. 83 5 2005 329 342 (Pubitemid 41201798)
5. G. Benagiano, and M. Farris Why a consensus conference on hormone replacement therapy and the cardiovascular system? Maturitas 47 4 2004 245 253 (Pubitemid 38520109)
6. I.F. Godsland Effects of postmenopausal hormone replacement therapy on lipid lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000 Fertil. Steril. 75 5 2001 898 915 (Pubitemid 32401667)
7. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, and R. Simes Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Lancet 366 9493 2005 1267 1278
8. M. Reilly, and D.J. Rader Apolipoprotein E and coronary disease: a puzzling paradox PLoS Med. 3 6 2006 e258
9. T. Nieminen, M. Kahonen, L.E. Viiri, P. Gronroos, and T. Lehtimaki Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease Pharmacogenomics 9 10 2008 1475 1486
10. S. Almeida, M. Fiegenbaum, F.M. de Andrade, M.C. Osorio-Wender, and M.H. Hutz ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy Maturitas 54 2 2006 119 126
11. M. Tsuda, M. Sanada, H. Nakagawa, I. Kodama, T. Sakashita, and K. Ohama Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy Maturitas 38 3 2001 297 304 (Pubitemid 32453207)
12. B.A. Laffitte, J.J. Repa, S.B. Joseph, D.C. Wilpitz, H.R. Kast, D.J. Mangelsdorf, and P. Tontonoz LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes Proc. Natl. Acad. Sci. U.S.A. 98 2 2001 507 512 (Pubitemid 32105072)
13. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 6 1972 499 502
14. L.A Salazar, M.H. Hirata, S.A. Cavalli, M.O. Machado, and R.D. Hirata Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing Clin. Chem. 44 8 Pt. 1 1998 1748 1750 (Pubitemid 28381222)
15. L.A. Salazar, M.H. Hirata, S.D. Giannini, N. Forti, J. Diament, T.M. Lima, and R.D. Hirata Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease Clin. Chim. Acta 300 1-2 2000 139 149 (Pubitemid 30665781)
16. F.D. Genvigir, A.C. Rodrigues, A. Cerda, S.S. Arazi, M.A. Willrich, R. Oliveira, M.H. Hirata, E.L. Dorea, M.M. Bernik, R. Curi, and R.D. Hirata Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells Pharmacogenomics 11 9 2010 1235 1246
17. P. Raggi, M. Davidson, T.Q. Callister, F.K. Welty, G.A. Bachmann, H. Hecht, and J.A. Rumberger Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) Circulation 112 4 2005 563 571 (Pubitemid 41060797)
18. M. Ushioda, K. Makita, K. Takamatsu, F. Horiguchi, and D. Aoki Serum lipoprotein(a) dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women Horm. Metab. Res. 38 9 2006 581 586 (Pubitemid 44569142)
19. D.M. Herrington, E. Vittinghoff, F. Lin, J. Fong, F. Harris, D. Hunninghake, V. Bittner, H.G. Schrott, R.S. Blumenthal, and R. Levy Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS) Circulation 105 25 2002 2962 2967 (Pubitemid 34693827)
20. A. Sima, A. Iordan, and C. Stancu Apolipoprotein E polymorphism - a risk factor for metabolic syndrome Clin. Chem. Lab. Med. 45 9 2007 1149 1153 (Pubitemid 47396270)
21. L.N. He, R.R. Recker, H.W. Deng, and V. Dvornyk A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females Maturitas 62 1 2009 37 41
22. C.N. Ferreira, M.G. Carvalho, A.P. Fernandes, L.M. Lima, A.A. Loures-Valle, J. Dantas, Z. Janka, A. Palotas, and M.O. Sousa Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders Neurochem. Int. 56 1 2010 177 182
23. F.M de-Andrade, M. Larrandaburu, S.M. Callegari-Jacques, G. Gastaldo, and M.H. Hutz Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population Braz. J. Med. Biol. Res. 33 5 2000 529 537
24. A. Wiegman, E.J. Sijbrands, J. Rodenburg, J.C. Defesche, S. de Jongh, H.D. Bakker, and J.J. Kastelein The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia Pediatr. Res. 53 6 2003 1008 1012 (Pubitemid 36667003)
25. Y. Huang Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases Curr. Opin. Lipidol. 21 4 2010 337 345
26. M. Tolosa, S. Peiro, J.T. Real, A. Cano, J.F. Ascaso, and R. Carmena The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause Maturitas 40 2 2001 173 181 (Pubitemid 33079177)
27. T. Lehtimaki, P. Dastidar, H. Jokela, T. Koivula, S. Lehtinen, C. Ehnholm, and R. Punnonen Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein e genotype J. Clin. Endocrinol. Metab. 87 9 2002 4147 4153
28. D.S. Christidis, E.N. Liberopoulos, A.I. Kakafika, G.A. Miltiadous, M. Cariolou, E.S. Ganotakis, D.P. Mikhailidis, and M.S. Elisaf The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate J. Cardiovasc. Pharmacol. Ther. 11 3 2006 211 221 (Pubitemid 44536190)
29. L.M. Mangravite, C.F. Thorn, and R.M. Krauss Clinical implications of pharmacogenomics of statin treatment Pharmacogenomics J. 6 6 2006 360 374 (Pubitemid 44811531)
30. J.Z. Guan, N. Tamasawa, H. Murakami, J. Matsui, J. Tanabe, K. Matsuki, M. Yamashita, and T. Suda HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in type 2 diabetic patients with hyperlipidemia J. Atheroscler. Thromb. 15 1 2008 20 25
31. G. Llaverias, A. Rebollo, J. Pou, M. Vazquez-Carrera, R.M. Sanchez, J.C. Laguna, and M. Alegret Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes Biochem. Pharmacol. 71 5 2006 605 614 (Pubitemid 43121994)
32. G. Llaverias, D. Lacasa, M. Vinals, M. Vazquez-Carrera, R.M. Sanchez, J.C. Laguna, and M. Alegret Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin Biochem. Pharmacol. 68 1 2004 155 163 (Pubitemid 38746551)
33. M. Kurano, O.N. Iso, M. Hara, N. Ishizaka, K. Moriya, K. Koike, and K. Tsukamoto LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL Lipids Health Dis. 10 2011 134
34. R.G Struble, B.P. Nathan, C. Cady, X. Cheng, and M. McAsey Estradiol regulation of astroglia and apolipoprotein E: an important role in neuronal regeneration Exp. Gerontol. 42 1-2 2007 54 63 (Pubitemid 44937823)
35. B.P. Nathan, A.G. Barsukova, F. Shen, M. McAsey, and R.G. Struble Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons Endocrinology 145 7 2004 3065 3073 (Pubitemid 38829971)
36. M.E. McAsey, C. Cady, L.M. Jackson, M. Li, S. Randall, B.P. Nathan, and R.G. Struble Time course of response to estradiol replacement in ovariectomized mice: brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed Exp. Neurol. 197 1 2006 197 205 (Pubitemid 41817233)
37. N. Srivastava, M. Averna, and R.A. Srivastava Dietary cholesterol and estrogen administration elevate brain apolipoprotein E in mice by different mechanisms Indian J. Biochem. Biophys. 45 6 2008 410 415